HIGHFDA DRUG

Nivagen Zinc Oxide Ointment Recalled Over cGMP Deviations

Nivagen Pharmaceuticals recalled 7,920 bottles of Zinc Oxide Ointment on October 31, 2025. The recall follows cGMP deviations that could impact product safety. Consumers should cease use immediately and consult healthcare providers for advice.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
October 31, 2025
Status
ACTIVE
Severity
7/10

Quick Facts at a Glance

Recall Date
October 31, 2025
Hazard Level
HIGH
Brands
NIVAGEN ZINC OXIDE, Nivagen Pharmaceuticals, Inc.
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
NIVAGEN ZINC OXIDE, Nivagen Pharmaceuticals, Inc.
Product type
Zinc Oxide Ointment
Model numbers
Lot #: A352505
UPC codes
75834-170, 75834-170-01, 75834-170-02, 75834-170-15
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    October 31, 2025

  2. Reported by FDA DRUG

    December 10, 2025

  3. RecallRadar source check

    December 17, 2025

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

cGMP deviations

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Blossom Pharmaceuticals or your healthcare provider for guidance. Notification method: Letter

About This Product

Nivagen Zinc Oxide Ointment is used for skin protection and is commonly purchased for its soothing and barrier properties for diaper rash and minor skin irritations.

Why This Is Dangerous

The cGMP deviations may result in inconsistencies in the product's formulation or contamination, posing risks to consumers.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers may face inconvenience and potential health risks if they continue to use the affected ointment.

Practical Guidance

How to identify if yours is affected

  1. Check the product label for the lot number A352505.
  2. Verify if the product has been used or is still unopened.
  3. Contact your healthcare provider for confirmation of the recall.

Where to find product info

The lot number can typically be found on the bottom of the tube or box packaging.

What timeline to expect

Refund processing may take 4-6 weeks.

If the manufacturer is unresponsive

  • Follow up with Blossom Pharmaceuticals after two weeks.
  • Contact the FDA for assistance if still unresolved.

How to prevent similar issues

  • Always check for product recalls before purchasing.
  • Look for FDA approval and cGMP certification when buying medications.
  • Consult with a healthcare provider for recommendations on safe alternatives.

Documentation advice

Keep receipts, correspondence with the manufacturer, and take photos of the product for your records.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recalled product is Nivagen Zinc Oxide Ointment USP, containing 20% zinc oxide, and packaged in 1 oz. (28.4 g) bottles. The lot number is A352505, and it was distributed nationwide in the USA.

Key Facts

  • Recall date: October 31, 2025
  • Report date: December 10, 2025
  • Quantity recalled: 7,920 bottles
  • Manufactured in India

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot #: A352505
UPC Codes
75834-170
75834-170-01
75834-170-02
+1 more
Affected States
ALL
Report Date
December 10, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more